Caveolin 3 anticorps (N-Term)
Aperçu rapide pour Caveolin 3 anticorps (N-Term) (ABIN926940)
Antigène
Voir toutes Caveolin 3 (CAV3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Chien, Souris, Rat (Rattus), Boeuf (Vache), Porc
-
Purification
- Purified
-
Immunogène
- CAV3 antibody was raised in rabbit using the N terminal of CAV3 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CAV3 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CAV3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Caveolin 3 (CAV3)
-
Autre désignation
- CAV3
-
Sujet
- CAV3 is a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Synonyms: Polyclonal CAV3 antibody, Anti-CAV3 antibody, caveolin 3 antibody.
-
Pathways
- Carbohydrate Homeostasis, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Negative Regulation of Transporter Activity
Antigène
-